Although PSMA overexpression in primary PCa was correlated with advanced tumor malignant status, some clinical guidelines advise against routine PSMA, inducing the possibility of more men presenting with locally advanced or de novo oligo-metastasis prostate cancer exists (23). The gene discussed is FOLH1; the disease is prostate carcinoma.